2023330_艾瑞咨询_中国生殖健康行业研究报告（45页）.pdf

2023.3 iResearch Inc.2/NIPT LDT 3 1 2 3 4 54 iResearch I 2030/&5 iResearch I 1/3 Database 0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80 2000 6500 3500 0 3500 6500 0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80 2022 6500 3500 0 3500 6500 1978 2013 2014 2000 34 2022 2050 6 iResearch I 2/3 2013,2015,2021 2022.7.25 17 2022.7.25 17 1 2022.2.21 16 2021.6.26 2019.07.15 2019 2030 7 3/3 2012 2022 2022 3.7 2120 8.6%2012 1.6%2012-2022 2012-2022 838 912 1045 1165 1307 1451 1685 1902 1843 2115 2120 8.8%14.6%11.5%12.2%11.0%16.1%12.9%-3.1%14.8%0.2%7.0%6.9%7.2%7.4%7.6%7.9%8.5%8.8%8.7%8.8%8.6%2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022%16510 18311 20167 21966 23821 25974 28228 30733 32189 35128 36883 10.9%10.1%8.9%8.4%9.0%8.7%8.9%4.7%9.1%5.0%2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022%8 iResearch I Harrison,L.,&Huntington,D.(2011).Sexual and reproductive health and development.The Lancet,377(9764),1868-1869.Santelli,J.,Ott,M.A.,Lyon,M.,Rogers,J.,Summers,D.,&Schleifer,R.(2006).Abstinence and abstinence-only education:A review of US policies and programs.Journal of Adolescent Health,38(1),72-81.9 iResearch I 10 1 2 3 4 511 iResearch I/NIPT B/12 iResearch I logo/13 iResearch I hCG 3D/4D E2 Pipelle 14 iResearch I-LDT LDT 01 02 03 LDT ICSI.15 iResearch I-&/16 1 2 3 4 5172.1-18 iResearch I WHO 2023 18.2%15%16%16%16%17%17%18%18%-200 14%15%16%17%18%19%2016 2017 2018 2019 2020 2021 2022e2023e%2530 30%50%-/20%/BMI19 iResearch I 1/2 38 7.1%81 15.1%160 29.9%88 16.4%87 16.2%56 10.4%26 4.9%21-25 26-30 31-35 2020 12 31 536 2022 30%1 2 406/200/1-5 6-10 11-15 16-2020 iResearch I 2/2 2020 91%42 10%2021 230-300 1 14 467-609 2021 35645149851753627%10%4%4%-30%-20%-10%0%10%20%30%02004006008001,0001,2002012 2016 2018 2019 2020(%2020 15%30%5 221 iResearch I CDC CDC 2023 33%ICSI 30%IVF 17/6.5-10 6000 4.1 1.2 8.3 2%6.2%3.2%2023e 9.2%20-44 ART 277.733%4060%IVF 11;22 iResearch I ART-IVF-EF-AIH AID AIH AID(IVF-ET)ICSI PGS/PGD)23 iResearch I 23 23 1 2 3 PGD/PGS 4 AIH/AID ICSI PGD/PGS/AIH/AID)IVF-ET)24 iResearch I 2023 IVF 2026 484 2021 8.2%2021 32%2021 29132521421817528334641148411.6%-34.0%1.9%-19.9%62.2%21.9%19.0%17.6%-300.0%-250.0%-200.0%-150.0%-100.0%-50.0%0.0%50.0%1002003004005006002018 2019 2020 2021 2022 2023e 2024e 2025e 2026e2018-2026e%2020-2022 2023 2018 252.2-/26 iResearch I 35/0.1%0.4%0.7%0.8%0.9%1.2%1.4%1.6%2.3%3.3%4.6%8.2%0%2%4%6%8%10%35 35 36 37 38 39 40 41 42 43 44 45%2018 2022 70%80%28 1 1 1 1 2021/2020/27 iResearch I12.1%10.3%9.5%8.9%8.1%7.5%6.8%6.1%5.6%5.4%5.0%0%2%4%6%8%10%12%14%2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 20212011-2021%93.7%95.0%95.6%96.2%96.5%96.6%96.5%96.6%96.8%97.4%97.6%91%92%93%94%95%96%97%98%2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 20212011-2021%/97.6%2021 2021 5%/1.2.3.)4.28 iResearch I DNA NIPT NIPT NIPT 99.99%70%60-80%98%99%90%0 0 0 1-2%0.5-1%1-2.3%1-2 1 1 3-4 3-4 3-4 0.1%NT 3%-5%2%5%0.1%1%0.5%1%0.5%1%21/18 15 20 25 30 13 16 26010 2211 NIPT12/29 iResearch INIPT NIPT NIPT NIPT NIPT 21 18 13 NIPT 21 13 18 99%12 NIPT 5-10ml 1 2 3 4 5 67 8 9 10 11 1213 14 15 16 17 1819 20 21 22 X Y 13 1/8000-1/5000 18 1/8000-1/5000 21 1/800-1/600 1/1000-1/5000 1p36 1/50000-1/20000Cri du chat 1/5000-1/3000 22q11 30 iResearch INIPT NIPT NIPT NIPT Non-Invasive Prenatal Testing NIPD Non-invasive Prenatal Genetic Diagnosis DNA NIPT NGS DNA DNA NIPT NIPT 1 2 3 4 DNA DNA DNA 6M-25M 90%21-31 iResearch I48688088909911112213341.7%17.1%9.9%2.1%10.1%12.5%9.7%9.2%-90.0%-70.0%-50.0%-30.0%-10.0%10.0%30.0%50.0%4060801001201401601802002018 2019 2020 2021 2022 2023e 2024e 2025e 2026e2018-2026e NIPT NIPT%NIPT NIPT NIPT NIPT NIPT NIPT 2026 NIPT 133 32 1 2 3 4 533 iResearch I-2003 IVF 1 24 635VIP 24h IVF 2019+PGS HRC PGS 2020 HRC Fertility IVF+34 iResearch I NIPT-NIPT NIPT NIPT&2021 9%NIPT EZ-PALO RUPA 2021 500 NextSeqCN500 4000 6 NIPT 3-5 7 2012 3 2016 3 P 2021 NIPT 500 Illumina Illumina Illumina SBS DNA DNA EZ-PALO Plus DNA DNA NextSeq CN500 NIPT CNVisi NIPT 2010 2017 NIPT+NIPT 35 iResearch I AI 40%B.3500+60%+500+-/app APP 1300 APP 500-100 36 1 2 3 4 537 iResearch I 1/4)38 iResearch I 2/4)LDT LDT LDT 2023 LDT 2023 LDT LDT LDT LDT LDT LDT laboratory developed test LDT ICL 2021 1 LDT 2022 1 2022 4-LDT LDT LDT LDT LDT 39 iResearch I 3/4)40 iResearch I 4/4)15%-30%5%-10%/3 3 41 iResearch I 42 IPO 43 2002 3000 400-026-Contact Us 44 45